Galectine-9 (LGALS9) Recombinant eiwit, humaan

The human Galectin-9 is a recombinant protein consisting of a single non-glycosylated polypeptide chain with 168 amino acids (1-148aa) . Immunotherapy, particularly immune checkpoint inhibitors, has revolution- ized cancer treatment by offering precise, targeted approaches. Galectin-9 (LGALS9), a protein from the galectin family, plays a significant role in immune regulation and tumor pathogenesis, impacting cancer prognosis. Known for its diverse physiological functions such as cell growth, different- iation, adhesion, and death, Galectin-9 interacts with its receptor Tim-3 to maintain immune homeostasis and tumor cell survival. Its expression levels influence tumor occurrence and metastasis, making it a potential target for cancer immunotherapy due to its ability to induce T-cell death and promote immunosuppression in the tumor microenvironment. Abbreviations: Urate transporter/channel protein, LGALS9A, Lectin galactoside-binding soluble 9, HUAT, Ecalectin, Galectin-9, HOM-HD-21, LGALS9

The human Galectin-9 is a recombinant protein consisting of a single non-glycosylated polypeptide chain with 168 amino acids (1-148aa) . Immunotherapy, particularly immune checkpoint inhibitors, has revolution- ized cancer treatment by offering...

Galectin-9 (LGALS9) Recombinant Protein, Human, 10ug

10μg / vial

Cell Signaling Pathways

0.5 mg/mL (Refer to the vial label for the concentration.)

> 95%, as determined by SDS-PAGE

Soluble

This protein is supplied in 20mM Tris-HCl (pH 8) 100mM NaCl, 20% glycerol.

18.5kDa

Stable at 4°C for one month or stored in the dark at -20°C long-term.

E. coli